Chemoinformaics analysis of emodin-1-o-beta-d-glucoside
| Molecular Weight | 796.962 | nRot | 7 |
| Heavy Atom Molecular Weight | 740.514 | nRig | 22 |
| Exact Molecular Weight | 796.405 | nRing | 9 |
| Solubility: LogS | -8.197 | nHRing | 6 |
| Solubility: LogP | 13.068 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 114 | No. of Aliphatic Hetero Cycles | 5 |
| No. of Heavy Atom | 58 | No. of Aromatic Carbocycles | 2 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 56 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 45 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 15 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 16 |
| nHA | 12 | APOL | 124.108 |
| nHD | 4 | BPOL | 70.2876 |
| QED | 0.074 |
| Synth | 4.728 |
| Natural Product Likeliness | 1.82 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.916 |
| MDCK | 0.00000451 |
| BBB | 0.071 |
| PPB | 1.03631 |
| VDSS | 5.034 |
| FU | 0.00593023 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.18 |
| CYP2c19-inh | 0.057 |
| CYP2c19-sub | 0.459 |
| CYP2c9-inh | 0.022 |
| CYP2c9-sub | 0.737 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.066 |
| CYP3a4-inh | 0.213 |
| CYP3a4-sub | 0.537 |
| CL | 6.644 |
| T12 | 0.001 |
| hERG | 0.061 |
| Ames | 0.018 |
| ROA | 0.014 |
| SkinSen | 0.526 |
| Carcinogencity | 0.019 |
| EI | 0.008 |
| Respiratory | 0.338 |
| NR-Aromatase | 0.263 |
| Antiviral | Yes |
| Prediction | 0.910926 |